期刊文献+

白细胞介素6对人单核/巨噬细胞系细胞表面Toll样受体4表达的影响 被引量:4

Effects of human interleukin-6 (IL-6) on the expression of Toll like receptor-4 (TLR4) of THP-1
原文传递
导出
摘要 目的:观察白细胞介素6(IL-6)对人单核/巨噬细胞系(THP-1)细胞表面Toll样受体4(TLR4)表达的影响。方法:流式细胞仪检测不同浓度IL-6(0ng/L、10ng/L、100ng/L、1μg/L、10μg/L、100μg/L)干预THP-1细胞24h,以及10μg/L的IL-6干预THP-1细胞不同的时间(0、3、6、12、24、48h)后细胞表面TLR4的表达水平。结果:各浓度IL-6均能不同程度的促进细胞表面TLR4的表达(P<0.05),以10μg/L组干预最为显著(P<0.01);10μg/LIL-6干预不同的时间后均可促进其表达,以干预24h后的差异最显著(P<0.01)。结论:IL-6可以促进人THP-1细胞表面TLR4表达,且具有一定的浓度和时间依赖性。 Objective:To explore the effects of IL-6 on the expression of Toll like receptor-4(TLR4) of THP-1. Methods:Flow Cytometry (FCM) was used to detect the expression of TLR4 of THP-1 cells,which was stimulated with different concertrations of IL-6 (0 ng / L,10 ng / L,100 ng / L,1 μg / L,10 μg / L and 100 μg / L),and on different time after treated with 10 μg / L IL-6 (0 h,3 h,6 h, 12 h,24 h,48 h). Results:Different concertrations of IL-6 can significantly promote the expression of TLR4 in THP-1 cells,especially under the concentration of 10 μg/L IL-6 group. Still this effect can be observed in 10 μg/L IL-6 group under treated for 3 h, 6 h,12 h, 24 h and 48 h,especially at 24 h. Conclusion:The expression of of TLR4 on THP-1 cells can be promoted by IL-6 in a dose-and timedependence.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2010年第3期319-323,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省卫生厅创新基金(XK12200903)
关键词 IL-6 THP-1 TLR4 IL-6 THP-1 TLR4
  • 相关文献

参考文献15

  • 1Akira S,Uematsn S,Takenehi O. Pathogen recogniti on and innate immunity[J]. Ce11,2006,124 (4) :783-801.
  • 2Medzhitov R,Preston-Hurburt P,Janeway CA. A human homologue of the Drosophila Toll protein signals activa- tion of adaptive immunity[J]. Nature, 1997,388 (6640) : 394-397.
  • 3Hosogai N,Fukuhara A, Oshima K,et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dys regulation[J]. Diabetes, 2007,56(4) : 901-911.
  • 4Tsujimoto H,Ono S,Efron PA,et al. Role of Toll-like receptors in the development of sepsi [J]. Shock, 2008,29 (3):315-321.
  • 5Gibson FC,Yumot oH,Takahashi Y,et al. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis[J]. J Dent Res,2006,85 (2):106-121.
  • 6Edfeldt K,Swedenborg J,Hansson GK,et al. Expression of toll-like receptors in human atherosclerotic lesions:a possible pathway for plaque activation [J]. Circulation, 2002,105 (10) : 1158-1161.
  • 7Boulanger MJ, Chow DC, Brevnova EE,et al. Hexameric structure and assembly of the interleukin-6/IL-6 alpha- receptor/gpl30 complex [J]. Science,2003,300(5628): 2101-2104.
  • 8Giuliani N, Colla S, Sala R,et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes:a potential role in multiple myeloma bone disease [J]. Blood,2002,100 (13) :4615-4621.
  • 9Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles:the signal orchestration model [J]. Rev Physiol Biochem Pharmacol,2003,149 (1).1-38.
  • 10Tsukumo DM,Carvalho-Filho MA,Carvalheria JB,et al. Loss-of-function in Toll-like receptor 4 perverts diet-induced obesisty and insulin resistance [J]. Diabetes, 2007,56(8) : 1986-1998.

二级参考文献12

  • 1Gibson FC,Yumoto H,Takahashi Y,et al.Innate immune signaling and porphyromonas gingivalis-accelerated atherosclerosis[J].J dent Res,2006,85(2):106-121.
  • 2Cario E,Podolsky DK.Toll-like receptor signaling and its relevance to intestinal inflammation[J].Ann N Y Acad Sci,2006,1072:332-338.
  • 3Goepfert AR,Varner M,Ward K,et al.Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy[J].Am J Obstet Gynecol,2005,193 (4):1478-1485.
  • 4Lin Y,Zeng Y,Zeng S,et al.Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption[J].Fertil-Steril,2006,85(Suppl 1):1125-1129.
  • 5Thornley TB,Brehm MA,Markees TG,et al.TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts[J].J Immunal,2006,176(3):1561-1570.
  • 6Obhrai J,Goldstein DR.The roll of toll-like receptors in solid organ transplantation[J].Transplantation,2006,81(4):497-502.
  • 7Romagne F.Current and future drugs targeting one class of innate immunity receptors:the Toll-like receptors[J].Drug Discov Today,2007,12(1-2):80-87.
  • 8Ishihara S,Rumi MA,Ortega-Cava CF,et al.Therapeutic targeting of toll-like receptors in gastrointestinal inflammation[J].Curr Pharm Des,2006,12(32):4215-4228.
  • 9Parker LC,Prince LR,Sabroe I.Translational Mini-Review Series on Toll-like Receptors:Networks regulated by Toll-like receptors mediate innate and adaptive immunity[J].Clin Exp Immunol,2007,147(2):199-207.
  • 10Delbridge LM,O'riordan MX.Innate recognition of intracellular bacteria[J].Curr Opin Immunol,2007,19(1):10-16.

共引文献6

同被引文献54

  • 1王首帆,徐爱琴,徐宜厚,朱立宏,秦宗碧,邱百怡.巴马汀对干扰素γ诱导的HaCaT细胞凋亡和炎症因子影响[J].中国临床药理学杂志,2020,36(3):327-331. 被引量:5
  • 2WEI Shu-qin, William F, LUO Zhong-cheng. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review[J]. Obstet Gynecol,2010,16(2) :393-401.
  • 3Kim Y M, Roberto, Haiworapongsa T. Toll-like receptor-2 and-4 in thechorioamniotic membranes in spontaneous labor at term and in preterm parturition that are associated with chorioanmionitis [ J ]. Am J Obstet Gynecol, 2004,191 ( 4 ) : 1346-1355.
  • 4Kaori K, Mssahiro N, Itaru Y, et al. Immunohistochemical Distribution of Toll-like receptors 4 in term and preterm human placentas from normal and complicated pregnancy including choriamnionitis [J].Human Patho1,2004 Jan,35 ( 1 ) :47-54.
  • 5Kumazaki K, Nakayama M, Yanagihara I, et al. distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy includin~ chorioamnionitis [ J ]. Hum Patho1.2004.35 (1) :47-54.
  • 6Wang H, Hirseh E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice : the role of toll-like receptor 4 [ J ]. Biology of Reproduction, 2003,69 ( 6 ) : 1957- 1963.
  • 7Kemp B, Menon R, Fortunato S J. Quantitation and localization of inflammatory cytokines interleukin-6 and interleukin-8 in the lower uterine segment during cervical dilatation[J]. J Assisted Reproduction and Genetics ,2004,19 ( 5 ) :215-219.
  • 8Makhseed M, Raghupathy R, E1-Shazly S, et al. Pro-inflammatory maternal cytokine profile in preterm delivery[J]. Am J Reprod Immuno1,2003 May ,49(5 ) :308-318.
  • 9Rose M V, Catherine K M, Andres R, et al. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm Infants [J]. Pediatr Res ,2004,55 (6) : 1009-1017.
  • 10Hodge D R, Hurt E M, Farrar W L. The role of I-6 and STAT3 in inflammation and cancer [ J ]. European Journal of Cancer, 2005,41 (16) ,2502-2512.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部